Yuzhakova E.V., Shanko Zh.G., Smirnova E.N.
Asymptomatic hyperuricemia in the practice of endocrinologist: Pleiotropic action of antihyperglycemic drugs
|
№8 / 2024
|
Mazurov V.I., Gaydukova I.Z., Tsinzerling A.Yu., Bashkinov R.A., Inamova O.V., Petrova M.S.
The effect of asymptomatic hyperuricemia on the frequency and structure of comorbidity patients with rheumatoid arthritis
|
№6 / 2022
|
Shcherbakova O.N., Pyko A.A., Safonkina O.S., Kuosa T.A., Likhotkina E.A., Popilov M.A.
Assessment of an integrated approach to the treatment of comorbid pathology using the enterosorption method
|
№1 / 2021
|
Grigorieva A.Yu., Amineva N.V., Asoskova A.V.
Difficulties in diagnostics and treatment of recurrent pulmonary embolism in comorbid pathology: a case from practice
|
№4 / 2019
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A.
Cystatin C as a marker of chronic kidney desease
|
№4 / 2019
|
L.B. Lazebnik, G.V. Belova
Systematizing classification of multifocal lesions of gastrointestinal mucosa caused by non-steroidal anti-inflammatory and antithrombotic agents (Moscow Classification)
|
№3 / 2018
|